Sunjay Kaushal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sunjay kaushal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sunjay Kaushal Today - Breaking & Trending Today

Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market - Longeveron (NASDAQ:LGVN), Amgen (NASDAQ:AMGN)

Advancements in healthcare and medicine have helped contribute to the reduction in child mortality rates, plummeting from 185 per 1,000 births a century ago to just 7 per 1,000 births in 2020. However, some serious pediatric conditions continue to pose a threat. ....

United States , Greg Olsen , Sunjay Kaushal , Food Drug Administration , Survival Rate For Phase , Principal Investigator , Orphan Drug Designation , Rare Pediatric Designation Longeveron , Drug Administration , Carlo Navarro ,